QHSLab, Inc.

USAQ ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2013 FY2012 FY2011 FY2010
Revenue $0 $0 $0 $0
Cost of Revenue — — — —
Gross Profit — — — —
Gross Margin — — — —
Operating Expenses
Research & Development — — — —
SG&A Expense $60.8K $60.5K $67.9K $53.7K
Operating Income $-69.9K $-69.6K $-77.0K $-62.8K
Operating Margin — — — —
Interest Expense $9.1K $9.1K $9.1K $9.1K
Pretax Income — — — —
Income Tax Expense — — — —
Net Income $-69.9K $-69.6K $-77.0K $-62.8K
Net Margin — — — —
EPS (Basic) $-0.06 — — —
EPS (Diluted) $-0.06 — — —
Shares Outstanding (Basic) 1.1M 1.1M 1.1M —
Shares Outstanding (Diluted) 1.1M 1.1M 1.1M —
Dividends Per Share — — — —
← Newer Page 2 of 2 Older →